Metraipolis › archive › dc_d64395fcb28d

Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment — Europe PMC PMID:42033356

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42033356
DOI: 10.1155/mi/4823996
License (as archived): solo-consultazione
Archived: 2026-11-07T04:15:38.915Z
SHA-256 of the archived text: f77d621c4d48f7c54d6689ed328e9b570aa1149b421730d32c0529daae05969e
Stable URL of this page: https://metraipolis.com/documento/dc_d64395fcb28d

How to cite

Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment — Europe PMC PMID:42033356 — Europe PMC (en), https://europepmc.org/article/MED/42033356 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d64395fcb28d (Metraipolis archive dc_d64395fcb28d, sha256 f77d621c4d48f7c54d6689ed328e9b570aa1149b421730d32c0529daae05969e)

BibTeX

@misc{dcd64395fcb28d,
  title = {Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment — Europe PMC PMID:42033356},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42033356},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d64395fcb28d; sha256 f77d621c4d48f7c54d6689ed328e9b570aa1149b421730d32c0529daae05969e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42033356. Agents can read the archived copy with the MCP tool read_document.